文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

丁酸盐预处理通过抗炎和抗氧化减轻内毒素诱导脓毒症小鼠模型的心脏抑制

Butyrate pretreatment attenuates heart depression in a mice model of endotoxin-induced sepsis via anti-inflammation and anti-oxidation.
PubMed 文献 · Am J Emerg Med · 2016-11-11
一句话结论小鼠实验中,丁酸盐(200 mg/kg·d)预处理3天可减轻LPS诱导的脓毒症心脏功能抑制、心肌形态学改变及炎症氧化指标恶化。

该研究为小鼠实验,将小鼠随机分为模型组(仅腹腔注射LPS 30 mg/kg)、丁酸盐组(LPS前给予丁酸盐200 mg/kg·d共3天)和正常组(仅生理盐水)。在LPS后6小时和12小时检测,丁酸盐预处理改善了心脏功能抑制(P<0.01),减轻了心肌形态学改变,并显著降低心脏组织中TNF-α、IL-6和LTB4的过表达(P<0.01),同时改善SOD、CAT活性和MDA含量(P<0.01或P<0.05)。结论认为丁酸盐预处理通过抗炎和抗氧化减轻脓毒症心脏抑制。

要点

  • 小鼠模型中,LPS 30 mg/kg腹腔注射后6小时和12小时,丁酸盐预处理(200 mg/kg·d,3天)改善心脏功能抑制(P<0.01)。
  • 丁酸盐预处理减轻LPS诱导的心肌形态学改变。
  • 丁酸盐预处理显著降低心脏组织TNF-α、IL-6和LTB4过表达(P<0.01)。
  • 丁酸盐预处理改善心脏SOD、CAT活性和MDA含量(P<0.01或P<0.05)。
  • 该研究为小鼠实验,丁酸盐为预处理给药,不能直接外推至临床脓毒症患者。

适用人群与场景

  • 小鼠(内毒素诱导脓毒症模型),非临床患者。

处置流程与药物剂量

  • 丁酸盐组:丁酸盐200 mg/kg·d预处理3天,随后腹腔注射LPS 30 mg/kg。
  • 模型组:仅腹腔注射LPS 30 mg/kg。
  • 正常组:仅给予生理盐水。
  • 给药途径:丁酸盐给药途径原文未写明。
  • 检测时间点:LPS给药后6小时和12小时。

研究设计与关键结果

  • 研究类型:小鼠实验;小鼠随机分为三组:模型组、丁酸盐组、正常组。
  • 丁酸盐预处理改善脓毒症心脏功能抑制(P<0.01),并减轻心肌形态学改变。
  • 丁酸盐预处理显著减轻心脏组织中TNF-α、IL-6和LTB4的过表达(P<0.01)。
  • 丁酸盐预处理明显改善心脏SOD、CAT活性和MDA含量(P<0.01或P<0.05)。
  • 结论:丁酸盐预处理通过抗炎和抗氧化减轻脓毒症心脏抑制。

证据类型、等级与局限

  • 证据类型:动物实验(小鼠模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该内容为小鼠实验,丁酸盐为预处理给药,原文结论为丁酸盐预处理通过抗炎和抗氧化减轻脓毒症心脏抑制,不能直接转化为脓毒症患者的临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: The depressed heart function is the main complication to cause death of septic patients in clinic. It is urgent to find effective interventions for this intractable disease. In this study, we investigated whether butyrate could be protective for heart against sepsis and the underlying mechanism.

METHODS: Mice were randomly divided into three groups. Model group challenged with LPS (30 mg/kg, i.p.) only. Butyrate group received butyrate (200 mg/kg·d) for 3days prior to LPS administration (30 mg/kg). Normal group received saline only. 6h and 12h after LPS administration were chosen for detection the parameters to estimate the effects or mechanism of butyrate pretreatment on heart of sepsis.

RESULTS: The data showed that septic heart depression was attenuated by butyrate pretreatment through improvement of heart function depression (P<0.01) and reduction of morphological changes of myocardium. The overexpression of proinflammatory factors, TNF-α, IL-6 and LTB4, in heart tissues induced by sepsis was significantly alleviated by butyrate pretreatment (P<0.01). As oxidative stress indicators, SOD and CAT activity, and MDA content in heart were deteriorated by LPS challenge, which was noticeably ameliorated by butyrate pretreatment (P<0.01 or P<0.05).

CONCLUSIONS: In conclusion, pretreatment with butyrate attenuated septic heart depression via anti-inflammation and anti-oxidation.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Wang F, Jin Z, Shen K, et al. Butyrate pretreatment attenuates heart depression in a mice model of endotoxin-induced sepsis via anti-inflammation and anti-oxidation. Am J Emerg Med. 2016. PMID: 27884587. doi:10.1016/j.ajem.2016.11.022

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。